What should I Know Regarding Pregnancy, Nursing and Administering Oseltamivir PHOSPHATE to Children or the Elderly?
If you are PREGNANT
- FDB Only When Necessary: LIMITED EPIDEMIOLOGICAL STUDIES SUGGEST NO INCREASED RISK OF BIRTH DEFECTS.
If you are NURSING
- Precaution: CDC REC CONTINUING BREASTFEEDING DURING ANTIVIRAL TREATMENT OR PROPHYLAXIS
If you are an adult over 60
Giving Oseltamivir PHOSPHATE to a child under 12
- management or monitoring precaution: Monitor for abnormal behavior. Possible risk of confusion, hallucination and seizure. Nausea and vomiting more common age < 1 year.
- management or monitoring precaution: Safety and efficacy not established age < 2 weeks. Risk of vomiting, diarrhea, behavioral changes.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.